Immunic (IMUX) Other Non-Current Assets (2013 - 2023)

Immunic has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $43000.0 for Q3 2023.

• Other Non-Current Assets for Q3 2023 came in at $43000.0, up 2.38% year-over-year; the trailing twelve-month figure through Sep 2023 was $43000.0 (up 2.38% YoY), and the FY2022 annual result was $43000.0, up 2.38% from the prior year.
• Other Non-Current Assets came in at $43000.0 for Q3 2023 at Immunic, roughly flat from $43000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $43000.0 in Q4 2022 to a low of $12000.0 in Q1 2019.
• The 5-year median for Other Non-Current Assets is $42000.0 (2019), against an average of $40470.6.
• Across the five-year window, Other Non-Current Assets tumbled 88.12% in 2019 and jumped 250.0% in 2020, its largest moves.
• Immunic's Other Non-Current Assets stood at $42000.0 in 2019, then changed by 0.0% to $42000.0 in 2020, then changed by 0.0% to $42000.0 in 2021, then rose by 2.38% to $43000.0 in 2022, then changed by 0.0% to $43000.0 in 2023.
• The last three Other Non-Current Assets figures came in at $43000.0 (Q3 2023), $43000.0 (Q2 2023), and $43000.0 (Q1 2023), per Business Quant data.